首页> 美国卫生研究院文献>Therapeutic Advances in Urology >Total testosterone in young men is more closely associated than free testosterone with prostate cancer disparities
【2h】

Total testosterone in young men is more closely associated than free testosterone with prostate cancer disparities

机译:与游离睾丸激素相比年轻男性的总睾丸激素与前列腺癌的差异更紧密相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Introduction: Early adulthood has been suggested as the most relevant time to determine the influence of testosterone on prostate carcinogenesis. For a more detailed assessment of this hypothesis, the present study examined whether serum total or free testosterone in young men was more closely associated with prostate cancer disparities.>Methods: A literature search was conducted for studies that reported both total and free testosterone levels for population samples of young men, along with prostate cancer incidences for the populations from which study populations were sampled. A previously developed analytical method was used to standardize the hormone levels of 19 population samples gathered from nine studies, and these standardized values were compared with disparities in prostate cancer incidence.>Results: Population differences in total testosterone levels were significantly associated with prostate cancer disparities, r = 0.833, p = 0.001, as were population differences in free testosterone, r = 0.661, p = 0.027. After controlling for age differences, total and free testosterone remained associated with prostate cancer disparities, partial r = 0.888, p < 0.001, and partial r = 0.657, p = 0.039, respectively. A marginally significant difference existed in the strength of relationships between total and free testosterone with respect to prostate cancer disparities, with total testosterone exhibiting a stronger association, T2 = 1.573, p = 0.077.>Conclusions: Across analyses, total testosterone demonstrated a more robust relationship than free testosterone with cancer disparities, which may suggest that total testosterone is the more sensitive biomarker for evaluating androgenic stimulation of the prostate gland.
机译:>简介:建议成年早期是确定睾丸激素对前列腺癌发生影响的最相关时间。为了对此假设进行更详细的评估,本研究检查了年轻男性的血清总睾丸激素水平或游离睾丸激素水平是否与前列腺癌差异更密切相关。>方法:进行了文献检索以研究报告这两种情况的人青年人群样本的总睾丸激素水平和游离睾丸激素水平,以及从中抽取研究人群的人群的前列腺癌发病率。使用先前开发的分析方法来标准化从九项研究中收集的19个人群样本的激素水平,并将这些标准化值与前列腺癌发病率的差异进行比较。>结果:总体睾丸激素水平的人群差异为与前列腺癌差异显着相关,r = 0.833,p = 0.001,游离睾丸激素的人群差异,r = 0.661,p = 0.027。在控制了年龄差异之后,总睾丸激素水平和游离睾丸激素水平仍与前列腺癌差异相关,分别为r partial = 0.888,p <0.001,部分r = 0.657,p = 0.039。就前列腺癌差异而言,总睾丸激素和游离睾丸激素之间的关系强度存在很小的显着差异,总睾丸激素表现出更强的关联性,T2 = 1.573,p = 0.077。>结论:总睾丸激素比游离睾丸激素与癌症的差异显示出更牢固的关系,这可能表明总睾丸激素是评估前列腺雄激素刺激的更敏感的生物标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号